What is Claritas Pharmaceuticals, Inc.'s annual revenue?

Claritas Pharmaceuticals, Inc. (CLAZF) reported annual revenue of $0 in its most recent fiscal year.

What is Claritas Pharmaceuticals, Inc.'s net profit?

Claritas Pharmaceuticals, Inc. (CLAZF) reported net profit of $4.0M in its most recent fiscal year.

What is CLAZF EV/EBITDA?

Claritas Pharmaceuticals, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 0.05.

OTC · Financial Statements

Claritas Pharmaceuticals, Inc. (CLAZF) Financial Statements

$0.00 OTC: CLAZF Market Cap $3659

Claritas Pharmaceuticals, Inc. most recently reported annual revenue of $0, net profit of $4.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric	2016	2017	2018	2019	2020
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-12.0M	$-14.0M	$-11.0M	$-9.0M	$-3.0M
Net Profit	$-12.0M	$-32.0M	$7.0M	$-21.0M	$4.0M
EPS	$-7.80	$-5.20	$0.64	$-1.00	$0.16
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2016	2017	2018	2019	2020
Total Assets	$5.0M	$65.0M	$60.0M	$25.0M	$10.0M
Total Liabilities	$2.0M	$77.0M	$50.0M	$29.0M	$9.0M
Cash	$1.0M	$4.0M	$0	$0	$0
Borrowings	$0	$3.0M	$0	$1.0M	$1.0M

Cash Flow (USD)

Metric	2016	2017	2018	2019	2020
Operating Cash Flow	$-2.0M	$-6.0M	$-5.0M	$-6.0M	$0
Investing Cash Flow	$0	$-10.0M	$0	$0	$0
Financing Cash Flow	$0	$0	$-2.0M	$0	$0
Net Cash Flow	$0	$3.0M	$-3.0M	$0	$0
Free Cash Flow	$-2.0M	$-6.0M	$-5.0M	$-6.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.05
FCF Yield	-8444.93%
Quick Ratio	0.14
Interest Coverage	-14.56
Return 1Y	0.00%
Return 3Y	-50.00%
Return 5Y	-99.97%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

CLAZF Overview CLAZF Dividend Run Stock Screener